��VR��Ƶ News - Research and innovation

Event | Nucleic Acids Seminar with Byron Purse

webfull — Mon, 16 Mar 2026 17:11:40 +0000

Fluorescent Nucleoside Analogues for Live-Cell Imaging of RNA Biology and Single-Molecule Studies

This Wednesday, March 18 at 11:00am-12:00pm, the Department of Chemistry is hosting a seminar on Nucleic Acids with Professor Byron Purse.

Published: 16 March 2026

Ten ��VR��Ƶ research projects receive $42 million from the Canada Foundation for Innovation

webfull — Fri, 13 Mar 2026 17:29:02 +0000

The Government of Quebec and partner organizations provide additional funding, bringing the total research investment to $106 million.

��VR��Ƶ was awarded $42 million through the Canada Foundation for Innovation’s Innovation Fund to support 10 research infrastructure projects led by researchers at the University.

Published: 13 March 2026

Call for Faculty: Join the 2026 ��VR��Ƶ Web Advisory Committee to help shape ��VR��Ƶ's digital spaces

webfull — Thu, 12 Mar 2026 18:08:56 +0000

��VR��Ƶ’s Web Advisory Committee is seeking a Faculty representative to help guide decisions that shape the health, accessibility, and long‑term evolution of ��VR��Ƶ's web ecosystem.

For 2026, they are looking for a Faculty member to join the committee.

Here are some of the ways you might contribute to the discussions.

Published: 12 March 2026

Two ��VR��Ƶ professors awarded 2026 Dorothy Killiam Fellowships

webfull — Wed, 11 Mar 2026 13:40:28 +0000

Professors Wendell Nii Laryea Adjetey and Jill Baumgartner will lead innovative research focusing on anti-Black carceral systems and climate-related health risks respectively

Published: 11 March 2026

Call for Applicants: Summer 2026 Internship

webfull — Wed, 04 Mar 2026 20:04:26 +0000

The HeDS-D2R Platform is seeking two interdisciplinary interns passionate about the intersection of biology, data science, and RNA therapeutics to join the team and contribute to a project that makes a real difference in the genomics and research community.

Two Project Tracks:

Published: 4 March 2026

CIHR and partners invest $7.9 million in cancer prevention research at ��VR��Ƶ

webfull — Thu, 26 Feb 2026 19:05:07 +0000

Part of the largest CIHR-led cancer prevention investment, ��VR��Ƶ researchers will develop approaches to reduce cancer risk and improve early detection

Published: 26 February 2026

Strengthening Global Capacity Through a New Partnership with the PATH RNA Cooperative and support from the Gates Foundation

webfull — Wed, 25 Feb 2026 16:15:11 +0000

Montreal, QC, February 25, 2026 - ��VR��Ƶ’s DNA to RNA (D2R) Initiative - a $165M initiative funded by the Government of Canada through the Canada First Research Excellence Fund to turn genomic discoveries into RNA-based treatments - is expanding its global health impact.

Published: 25 February 2026

A fast way to showcase your research: a new, ready-to-customize website template

webfull — Thu, 19 Feb 2026 18:20:59 +0000

��VR��Ƶ Researchers - as part of an initiative led by the ��VR��Ƶ Web Services team, it is now possible to request a centrally supported website to showcase your research or lab in the new WMS system, complete with a new specially designed, ready-to-customize website template.

Main features included:

Attractive, image-based layouts pre-filled with placeholder content for easy updates.

Published: 19 February 2026

D2R X Norton Rose Fulbright | Protecting Your Ideas: A Guide for Innovators

webfull — Tue, 17 Feb 2026 19:40:22 +0000

“Innovation” is everywhere these days—but beyond the buzzword, what does it really mean for a young company, and how can you turn it into a concrete competitive advantage? This presentation demystifies intellectual property (IP) and shows why it matters far more than many founders think.

We’ll explore briefly the different forms of IP and clarify what each protects in practical terms. You’ll discover when an idea becomes an “invention,” when you should consider filing a patent, and who the right professionals are to guide you along the way.

Published: 17 February 2026

D2R X NRC Biomanufacturing Collaboration Event

webfull — Tue, 17 Feb 2026 19:35:18 +0000

A half day showcase of D2R and the National Research Council’s shared biomanufacturing and bioengineering research priorities. Researchers from both the NRC and the D2R community will present on their platform and biomanufacturing-aligned work, including gene editing, mRNA production and optimization, lipid nanoparticle formulation, and RNA therapeutic delivery systems.